Status:
NOT_YET_RECRUITING
Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 Levels
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Growth Hormone Deficiency
Eligibility:
All Genders
5-18 years
Phase:
NA
Brief Summary
The METAB-BELGROW-LAGH study aims to prospectively evaluate the metabolic outcomes of Belgian children diagnosed with growth hormone deficiency (GHD) over a three-year period following the initiation ...
Eligibility Criteria
Inclusion
- Diagnosed with growth hormone deficiency (GHD)
- Treated with growth hormone (rhGH or LAGH)
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2031
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07173036
Start Date
December 1 2025
End Date
September 1 2031
Last Update
December 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.